BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Diagnosis
4 results:

  • 1. Is omission of free text records a possible source of data loss and bias in Clinical Practice Research Datalink studies? A case-control study.
    Price SJ; Stapley SA; Shephard E; Barraclough K; Hamilton WT
    BMJ Open; 2016 May; 6(5):e011664. PubMed ID: 27178981
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.
    Massironi S; Conte D; Sciola V; Spampatti MP; Ciafardini C; Valenti L; Rossi RE; Peracchi M
    Am J Gastroenterol; 2010 Sep; 105(9):2072-8. PubMed ID: 20372113
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Serum DU-PAN-2 in the differential diagnosis of pancreatic cancer: influence of jaundice and liver dysfunction.
    Fabris C; Malesci A; Basso D; Bonato C; Del Favero G; Tacconi M; Meggiato T; Fogar P; Panozzo MP; Ferrara C
    Br J Cancer; 1991 Mar; 63(3):451-3. PubMed ID: 2003987
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Somatostatinoma: a case report and review of the literature.
    Harris GJ; Tio F; Cruz AB
    J Surg Oncol; 1987 Sep; 36(1):8-16. PubMed ID: 3041116
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.